Cargando…
Novel and Potent Dopamine D(2) Receptor Go-Protein Biased Agonists
[Image: see text] The discovery of functionally biased and physiologically beneficial ligands directed toward G-protein coupled receptors (GPCRs) has provided the impetus to design dopamine D(2) receptor (D(2)R) targeted molecules that may be therapeutically advantageous for the treatment of certain...
Autores principales: | Bonifazi, Alessandro, Yano, Hideaki, Guerrero, Adrian M., Kumar, Vivek, Hoffman, Alexander F., Lupica, Carl R., Shi, Lei, Newman, Amy Hauck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371206/ https://www.ncbi.nlm.nih.gov/pubmed/30775693 http://dx.doi.org/10.1021/acsptsci.8b00060 |
Ejemplares similares
-
Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor
por: Adhikari, Pramisha, et al.
Publicado: (2021) -
Subtle Structural
Modification of a Synthetic Cannabinoid
Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor
por: Yano, Hideaki, et al.
Publicado: (2023) -
A subtle structural modification of a synthetic cannabinoid receptor agonist drastically increases its efficacy at the CB1 receptor
por: Yano, Hideaki, et al.
Publicado: (2023) -
Highly Potent and
Selective Dopamine D(4) Receptor Antagonists Potentially
Useful for the Treatment of Glioblastoma
por: Pavletić, Pegi, et al.
Publicado: (2022) -
Tranylcypromine Substituted cis-Hydroxycyclobutylnaphthamides
as Potent and Selective Dopamine D(3) Receptor Antagonists
por: Chen, Jianyong, et al.
Publicado: (2014)